Trials / Conditions / Acute Myeloid Leukemia, Relapsed, Adult
Acute Myeloid Leukemia, Relapsed, Adult
6 registered clinical trials studyying Acute Myeloid Leukemia, Relapsed, Adult — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA NCT06802315 | University of Illinois at Chicago | Phase 2 |
| Terminated | Natural Killer-cell Therapy for Acute Myeloid Leukemia NCT04347616 | Radboud University Medical Center | Phase 1 / Phase 2 |
| Recruiting | CLAG-GO for Patients With Persistent, Relapsed or Refractory AML NCT04050280 | University of Maryland, Baltimore | Phase 2 |
| Completed | CDIAG Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia NCT03985007 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Terminated | Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia NCT03063203 | Washington University School of Medicine | Phase 2 |
| Terminated | A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Ve NCT02957032 | Philogen S.p.A. | Phase 1 |